L DOPA Reverses the Increased Free Amino Acids Tissue Levels Induced by Dopamine Depletion and Rises GABA and Tyrosine in the Striatum
Perturbations in the cerebral levels of various amino acids are associated with neurological disorders, and previous studies have suggested that such alterations have a role in the motor and non motor symptoms of Parkinson's disease. However, the direct effects of chronic L DOPA treatment, that produces dyskinesia, on neural tissue amino acid concentrations have not been explored in detail. To evaluate whether striatal amino acid concentrations are altered in peak dose dyskinesia, 6 hydroxydopamine (6 OHDA) lesioned hemiparkinsonian mice were treated chronically with L DOPA and tissue amino acid concentrations were assessed by HPLC analysis. These experiments revealed that neither 6 OHDA nor L DOPA treatment are able to alter glutamate in the striatum. However, glutamine increases after 6 OHDA and returns back to normal levels with L DOPA treatment, suggesting increased striatal glutamatergic transmission with lack of dopamine. In addition, glycine and taurine levels are increased following dopamine denervation and restored to normal levels by L DOPA. Interestingly, dyskinetic animals showed increased levels of GABA and tyrosine, while aspartate striatal tissue levels are not altered. Overall, our results indicate that chronic L DOPA treatment, besides normalizing the altered levels of some amino acids after 6 OHDA, robustly increases striatal GABA and tyrosine levels which may in turn contribute to the development of L DOPA induced dyskinesia.
Neurotoxicity Research